Detect and confirm mycoplasma contamination in cell culture, biologics, and cell therapy materials using PCR and culture-based detection methods.
Mycoplasma contamination is the most common and most destructive quality issue in cell culture — affecting >30% of cell lines at some institutions.
Mycoplasma lack cell walls and don't cloud media, making them invisible without dedicated testing.
PCR-based detection provides same-day or next-day results for rapid lot release decisions.
Cell lines used in biologics manufacturing must demonstrate mycoplasma-free status. We provide documentation for GMP support.
CAR-T and other cell therapy programs require mycoplasma testing at multiple manufacturing stages.
PCR for rapid screening, culture for regulatory-grade confirmation.
Submitting takes less than 5 minutes. Most projects turn around in 5–10 business days from sample receipt.
Fill out our sample intake form — sample type, quantity, and timeline. We confirm turnaround and quote within one business day.
We'll send submission instructions and our San Diego shipping address. Most samples ship ambient or cold depending on stability requirements.
Results are delivered as a signed PDF COA within the agreed turnaround. Rush service (2–3 business days) available for urgent timelines.
PCR provides rapid results (1–2 days) and high sensitivity but cannot distinguish viable from non-viable organisms. Culture-based testing (14–28 days) is considered the gold standard for regulatory submissions and detects viable organisms only.
Yes. We offer PCR-only, culture-only, or combined testing depending on your timeline and regulatory requirements.
Cell-conditioned media, culture supernatant, cell lysates, and finished biologics are all acceptable. Contact us if you have an unusual matrix.
Submit your samples and receive a Certificate of Analysis. Results in 5–10 business days.